Serina Therapeutics (SER) Accumulated Depreciation & Amortization (2017 - 2025)
Historic Accumulated Depreciation & Amortization for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to $650000.0.
- Serina Therapeutics' Accumulated Depreciation & Amortization rose 4099.78% to $650000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $650000.0, marking a year-over-year increase of 4099.78%. This contributed to the annual value of $601000.0 for FY2024, which is 5410.26% up from last year.
- Latest data reveals that Serina Therapeutics reported Accumulated Depreciation & Amortization of $650000.0 as of Q3 2025, which was up 4099.78% from $634000.0 recorded in Q2 2025.
- Over the past 5 years, Serina Therapeutics' Accumulated Depreciation & Amortization peaked at $650000.0 during Q3 2025, and registered a low of $227000.0 during Q1 2021.
- Over the past 4 years, Serina Therapeutics' median Accumulated Depreciation & Amortization value was $461000.0 (recorded in 2024), while the average stood at $492333.3.
- Per our database at Business Quant, Serina Therapeutics' Accumulated Depreciation & Amortization changed by 0.0% in 2021 and then soared by 5410.26% in 2024.
- Quarter analysis of 4 years shows Serina Therapeutics' Accumulated Depreciation & Amortization stood at $227000.0 in 2021, then soared by 71.81% to $390000.0 in 2023, then soared by 54.1% to $601000.0 in 2024, then grew by 8.15% to $650000.0 in 2025.
- Its last three reported values are $650000.0 in Q3 2025, $634000.0 for Q2 2025, and $618000.0 during Q1 2025.